You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient

Article metrics

Article menu

Download PDFPDF

Case Reports
Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient

 

Online download statistics by month:

Online download statistics by month: December 2019 to August 2024

AbstractFullPdf
Dec 2019221
Jan 202013135
Feb 202016162
Mar 2020882
Apr 202013130
May 202022225
Jun 202019197
Jul 2020993
Aug 2020660
Sep 202023233
Oct 202026264
Nov 202024243
Dec 202020205
Jan 202116165
Feb 202123233
Mar 202132323
Apr 202130305
May 202114144
Jun 202123233
Jul 202121212
Aug 202116162
Sep 202115153
Oct 202110103
Nov 202121213
Dec 2021222212
Jan 202232331
Feb 2022293510
Mar 202221211
Apr 202241424
May 202233333
Jun 202246461
Jul 202247485
Aug 202255553
Sep 202253531
Oct 202249497
Nov 2022528915
Dec 202244549
Jan 202355565
Feb 202372721
Mar 202359609
Apr 2023444516
May 202356579
Jun 202346454
Jul 2023383812
Aug 202342421
Sep 202396977
Oct 202315015010
Nov 20231571573
Dec 2023454510
Jan 202437386
Feb 202451515
Mar 2024484910
Apr 202453533
May 202438416
Jun 202433335
Jul 202468718
Aug 202466685
Total22002270283